“Anakinra, a Recombinant Human IL-1 Receptor Antagonist, in Clinical Practice. Outcome in 60 Patients With Severe Rheumatoid Arthritis”. Reumatismo 59, no. 1 (March 30, 2007): 32–37. Accessed June 7, 2025. https://www.reumatismo.org/reuma/article/view/reumatismo.2007.32.